DHDDS-congenital disorder of glycosylation

Clinical trials for DHDDS-congenital disorder of glycosylation explained in plain language.

Never miss a new study

Get alerted when new DHDDS-congenital disorder of glycosylation trials appear

Sign up with your email to follow new studies for DHDDS-congenital disorder of glycosylation, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Could a common supplement help a rare disease? early trial begins

Disease control Recruiting now

This early-stage trial is testing the safety of a dietary supplement called NMN in 8 people with a rare genetic disorder known as DHDDS-CDG, which affects movement and development. Participants will take 250 mg of NMN daily for 6 months, with an optional 12-month follow-up. The m…

Matched conditions: DHDDS-CONGENITAL DISORDER OF GLYCOSYLATION

Phase 1 • Sponsor: Eva Morava-Kozicz • Aim: Disease control

Last updated Jun 27, 2026 14:01 UTC

DHDDS-congenital disorder of glycosylation

Get alerted when new DHDDS-congenital disorder of glycosylation trials appear

Could a common supplement help a rare disease? early trial begins